My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.

    Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE.

    Diabetes Care. 2002 Feb;25(2):275-8.PMID: 11815495 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.

    Kilpatrick ES, Rigby AS, Atkin SL.

    Clin Chem. 2007 May;53(5):897-901. Epub 2007 Mar 23.PMID: 17384010 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?

    Hillman N, Herranz L, Grande C, Vaquero PM, Pallardo LF.

    Diabet Med. 2004 May;21(5):468-70.PMID: 15089792 [PubMed - indexed for MEDLINE]Related articles

    4.

    Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.

    Brennan AL, Gyi KM, Wood DM, Hodson ME, Geddes DM, Baker EH.

    J Cyst Fibros. 2006 Jan;5(1):27-31. Epub 2005 Sep 30.PMID: 16202666 [PubMed - indexed for MEDLINE]Related articles

    5.

    No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.

    Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L, Rabasa-Lhoret R.

    Diabetes Metab. 2008 Dec;34(6 Pt 1):568-73. Epub 2008 Oct 14.PMID: 18922724 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

    Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M.

    Diabetes Care. 2001 Dec;24(12):2023-9.PMID: 11723077 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.

    Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E.

    Diabetes Care. 2002 Oct;25(10):1840-4.PMID: 12351488 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.

    Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M.

    Diabet Med. 2006 Oct;23(10):1151-4.PMID: 16978383 [PubMed - indexed for MEDLINE]Related articles

    9.

    Is HbA(1c) affected by glycemic instability?

    Derr R, Garrett E, Stacy GA, Saudek CD.

    Diabetes Care. 2003 Oct;26(10):2728-33.PMID: 14514571 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    11.

    Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

    Avignon A, Radauceanu A, Monnier L.

    Diabetes Care. 1997 Dec;20(12):1822-6.PMID: 9405900 [PubMed - indexed for MEDLINE]Related articles

    12.

    Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.

    McCarter RJ, Hempe JM, Gomez R, Chalew SA.

    Diabetes Care. 2004 Jun;27(6):1259-64.PMID: 15161772 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Interindividual divergence in the relationship between the values of plasma glucose and hemoglobin A1c in type 2 diabetes.

    Fukudome M, Nakazaki M, Fukushige E, Koriyama N, Ikeda Y, Kato K, Kimura T, Tei C.

    Intern Med. 2009;48(5):273-9. Epub 2009 Mar 2.PMID: 19252347 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Relationship between glycated haemoglobin levels and mean glucose levels over time.

    Nathan DM, Turgeon H, Regan S.

    Diabetologia. 2007 Nov;50(11):2239-44. Epub 2007 Sep 13.PMID: 17851648 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

    Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

    Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

    Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y; Osaka CKD Expert Research Group.

    J Am Soc Nephrol. 2007 Mar;18(3):896-903. Epub 2007 Jan 31.PMID: 17267743 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.

    Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A.

    Diabet Med. 2008 Feb;25(2):174-8.PMID: 18290858 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

    Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

    Clin Ther. 2004 May;26(5):724-36.PMID: 15220016 [PubMed - indexed for MEDLINE]Related articles

    19.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity